Cargando…
Meganucleases and Other Tools for Targeted Genome Engineering: Perspectives and Challenges for Gene Therapy
The importance of safer approaches for gene therapy has been underscored by a series of severe adverse events (SAEs) observed in patients involved in clinical trials for Severe Combined Immune Deficiency Disease (SCID) and Chromic Granulomatous Disease (CGD). While a new generation of viral vectors...
Autores principales: | Silva, George, Poirot, Laurent, Galetto, Roman, Smith, Julianne, Montoya, Guillermo, Duchateau, Philippe, Pâques, Frédéric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3267165/ https://www.ncbi.nlm.nih.gov/pubmed/21182466 http://dx.doi.org/10.2174/156652311794520111 |
Ejemplares similares
-
Targeted Gene Therapy of Xeroderma Pigmentosum Cells Using Meganuclease and TALEN™
por: Dupuy, Aurélie, et al.
Publicado: (2013) -
Molecular basis of engineered meganuclease targeting of the endogenous human RAG1 locus
por: Muñoz, Inés G., et al.
Publicado: (2011) -
Efficient gene targeting mediated by a lentiviral vector-associated meganuclease
por: Izmiryan, Araksya, et al.
Publicado: (2011) -
Efficient design of meganucleases using a machine learning approach
por: Zaslavskiy, Mikhail, et al.
Publicado: (2014) -
Computer design of obligate heterodimer meganucleases allows efficient cutting of custom DNA sequences
por: Fajardo-Sanchez, Emmanuel, et al.
Publicado: (2008)